Clinical Trial Update: Bortezomib Maintenance in High Risk DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial update on bortezomib maintenance in high-risk diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN